# Liraglutide for Low-responders After Bariatric Surgery

> **NCT04643301** · NA · WITHDRAWN · sponsor: **Zuyderland Medisch Centrum**

## Conditions studied

- Obesity
- Obesity, Morbid

## Interventions

- **DRUG:** Liraglutide Pen Injector

## Key facts

- **NCT ID:** NCT04643301
- **Lead sponsor:** Zuyderland Medisch Centrum
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12-21
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Cancellation by sponsor
- **Last updated:** 2021-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04643301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04643301, "Liraglutide for Low-responders After Bariatric Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04643301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*